Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Allogeneic ABCB5+ mesenchymal stem cells for treatment-refractory chronic venous ulcers: a phase I/IIa clinical trial
In an unmatched population-based casecontrol approach, we estimated a sample size of 258 individuals with QUANTO software, version 1.2.4, assuming a log-additive inheritance model at 5% significance and 80% power and using the following parameters based on our previous study 20 : an environmental exposure to Hg of 2.5%, a population risk of reduced estimated glomerular filtration rate (eGFR
E., Cambiaghi, M., & Tesei, A
[5] Simeon A et al
Over the past decade, broadly HIV-1 neutralizing antibodies (bNAbs) were discovered that are up to a 1000-fold more potent than HIV-1-reactive antibodies previously described
US$ 23.13
US$ 22.53
US$ 28.78
